Find British Society for Rheumatology on Social Media
British Society for Rheumatology Annual Conference 2018
Start:
Tue, 1 May 2018, 08:00
End:
Thu, 3 May 2018, 03:00
Website:
Hashtag:
#BSR18
Venue:
The ACC & Exhibition Centre Liverpool
Kings Dock, Liverpool Waterfront
Liverpool, England L3 4FP
United Kingdom
Liverpool, England L3 4FP
United Kingdom
Exhibit
Symposia
Workshops
Organiser
Sponsor
The UK’s leading rheumatology event brings together more than 2000 delegates from 45 countries and features a world class programme of sessions, workshops, poster tours, symposia and over 40 exhibitors showcasing the latest developments and advances in rheumatology. This three day event offers you an unparalleled opportunity to expand your knowledge and network with other specialist health professionals.
CPD credits
Our CPD is approved by the Federation of the Royal College of Physicians.
Up to 18 CPD credits will be available for attendees.
Registrations have now closed
Registrations will be available on site.
A late fee will be applied.
Tuesday 1 May | ||
07:30 | Registration and exhibition opens | Rooms / location |
09:00 - 10:30 | Morning sessions | |
Biologics dose reduction: translating research into practice | 3B | |
Hot topics oral abstracts session | 12 | |
Myositis - SIG | 1C | |
Treatment approaches in osteoarthritis | 4 | |
Update on psoriatic arthritis | 3A | |
Work is good for health: a practical guide for rheumatologists | 11B | |
10:30 - 11:30 | Refreshment break, posters and exhibition | Exhibition hall |
10:35 - 11:25 | Editor's picks poster tour | Exhibition hall |
10:40 - 11:25 | Case reports poster tour | Exhibition hall |
10:40 - 11:20 | Innovation session | Innovation theatre |
10:40 - 11:20 | Celgene - Choosing the right door for your patient | Innovation theatre |
11:30 - 13:15 | Jewels in the Crown | Main Auditorium |
13:15 - 14:05 | Sponsored sessions | |
13:15 - 14:05 | Janssen - The debate: should safety drive biologic choice in PsA? | 3B |
13:15 - 14:15 | Lunch, posters and exhibition | Exhibition hall |
13:15 - 14:15 | Latest project news from the British Society for Rheumatology Biologics Registers | 3A |
13:20 - 14:00 | Innovation session | Innovation theatre |
13:20 - 14:00 | Roche - Are steroids always the answer? The case for
steroid-sparing in | Innovation theatre |
14:15 - 15:45 | Afternoon sessions | |
British Society for Rheumatology Biologics Registers: a scientific update | 3A | |
Interstitial lung disease and the rheumatologist in 2018 | 3B | |
Nursing impact on patient care and clinical research | 12 | |
Osteoarthritis - SIG | 11A | |
Rheumatoid arthritis oral abstracts session | 11B | |
Rheumatologists in training: developing your niche in rheumatology | 4 | |
Spondyloarthritis -SIG | 1B | |
Survival, but at what cost? | 1C | |
Work and health - SIG | 11C | |
15:45 - 16:15 | Refreshment break, posters and exhibition | Exhibition hall |
15:50 - 16:10 | Innovation session | Innovation theatre |
15:50 - 16:10 | Pfizer - Is there an opioid crisis in rheumatology? | Innovation theatre |
16:15 - 17:15 | Heberden Round | Main Auditorium |
17:00 | Exhibition closes | |
17:30 - 19:00 | Sponsored sessions | |
17:30 - 19:00 | AbbVie - Developing, assessing, and implementing
new treatments for rheumatology: | 3B |
17:30 - 19:00 | Roche / Chugai - Challenging current clinical practice in
Rheumatoid Arthritis (RA) | 11B + C |
18:00 | Registration closes | |
18:00 - 20:00 | Networking events | |
18:00 - 20:00 | Presidents welcome reception | Level 3 Foyer, ACC, Liverpool |
Wednesday 2 May | ||
Registration and exhibition opens | Rooms / location | |
07:15 - 08:45 | Morning special interest group sessions | |
Ethnicity and rheumatology - SIG | 11A | |
Heritable disorders of connective tissue - SIG | 4 | |
Physical activity - SIG | 3A | |
Sjögren's - SIG | 12 | |
09:00 - 10:30 | Morning sessions | |
Essentials 1: symptom management | 1A+B | |
Lung - SIG | 11A | |
Osteoporotic vertebral fractures | 11B+C | |
Scleroderma oral abstracts session | 12 | |
The impact of metabolic re-programming on rheumatologic diseases- co-badged by the British Society for Immunology | 3A | |
Travelling and rheumatic diseases - co-badged by the Liverpool School of Tropical Medicine | 1C | |
Ultrasound - SIG | 4 | |
Waking up to sleep problems in rheumatic diseases | 3B | |
10:30 - 11:30 | Refreshment break, posters and exhibition | Exhibition hall |
10:40 - 11:25 | Connective tissue disorders poster tour | Exhibition hall |
10:40 - 11:25 | Spondyloarthropathies poster tour | Exhibition hall |
10:40 - 11:20 | Innovation session | Innovation theatre |
10:40 - 11:20 | Janssen - The scope of enthesitis and enthesopathy in psoriatic disease | Innovation theatre |
11:30 - 13:00 | Late morning / Early afternoon sessions | |
Essentials 2: disease management | 1A+B | |
Establishing and embedding an ultrasound service within rheumatology | 4 | |
Infections in rheumatology - SIG | 1C | |
Patient activation: what is it, why does it matter, and what do I need to know? | 11A | |
Something for nothing: the value of automatic data collection | 11B+C | |
Vasculitis and connective tissue disorders oral abstracts session | 13 | |
What drives inflammation and how we can regulate it?- co-badged by the British Society for Immunology | 3A | |
13:00 - 14:30 | Lunch, posters and exhibition | Exhibition hall |
British Society for Rheumatology AGM | 12 | |
13:15 - 14:05 | Sponsored sessions | |
13:15 - 14:05 | Novartis - IL-17A inhibition: Opening the window of opportunity in PsA | 3B |
13:20 - 14:00 | Innovation session | Innovation theatre |
13:20 - 14:00 | Lilly - The JAK/STAT pathway: Understanding the Science | Innovation theatre |
14:30 - 16:00 | Afternoon sessions | |
Enhancing multidisciplinary teams working in the care of patients with inflammatory arthritis | 3B | |
Essentials 3: experts in the field | 1A+B | |
Osteoporosis - SIG - | 11A | |
Paediatric and adolescent rheumatology oral abstracts session | 11B+C | |
Adverse immune reactions triggered by cancer immunotherapy - co-badged by the British Society for Immunology | 3A | |
Rheumatologists in training: thinking outside the joint | 4 | |
Rheumatology in developing countries: what can we learn in the UK? - co-badged by the Liverpool School of Tropical Medicine | 1C | |
16:00 - 16:30 | Refreshments break, posters and exhibition | Exhibition hall |
16:05 - 16:25 | Innovation session | Innovation theatre |
16:05 - 16:25 | Bristol-Myers Squibb - Assessing RA disease activity: is DAS failing us? | Innovation theatre |
16:30 | Exhibition closes | |
16:30 - 17:30 | Heberden Oration | Main Auditorium |
17:30 | Registration closes | |
17:30 - 19:00 | Sponsored sessions | |
17:30 - 19:00 | Novartis - Technology and innovation: Reshaping AS practice | 3B |
17:45 - 21:00 | Networking events | |
17:45 - 19:15 | Trainee reception | The Lounge, Exhibition centre |
19:30 - 21:00 | The Quiz | Revolucion de Cuba, Albert Dock |
Thursday 3 May | ||
5K Fun run | Exhibition centre, main entrance | |
08:00 | Registration and exhibition opens | Rooms / location |
09:00 - 10:30 | Morning sessions | |
BHPR oral abstracts session | 1C | |
Foot and ankle - SIG | 4 | |
Glucocorticoids in rheumatic diseases: the evidence basis | 1B | |
No health without mental health: impact of mood problems in patients with rheumatic disorders | 11A | |
The brain in rheumatology | 12 | |
The national early inflammatory arthritis audit (NEIA Audit) | 11B+C | |
Uveitis: working together with ophthalmologists | 3 | |
10:30 - 11:30 | Refreshment break, posters and exhibition | Exhibition hall |
10:40 - 11:25 | Health professionals (Non-GMC registered) poster tour | Exhibition hall |
10:40 - 11:25 | Rheumatoid arthritis poster tour | Exhibition hall |
10:40 - 11:0 | Innovation session | Innovation theatre |
10:40 - 11:20 | Celgene - Choosing the right door for your patient | Innovation theatre |
11:30 - 13:00 | Late morning / Early afternoon sessions | |
Basic Science oral abstracts session | 1C | |
Droitwich lecture and Barbara Ansell address | 3 | |
Pain - SIG | 12 | |
Quality improvement through service peer review | 1B | |
Rheumatologists in training: | 4 | |
13:00 - 14:15 | Lunch, posters and exhibition | Exhibition hall |
13:00 - 14:15 | Specialist commissioning -SIG | 12 |
13:15 - 14:05 | Sponsored sessions | |
13:15 - 14:05 | Pfizer - XELJANZ®▼ (tofacitinib citrate): Exploring more than 4 years of Swiss experience | 11B + C |
13:20 - 14:00 | Innovation session | Innovation theatre |
13:20 - 14:00 | Sobi - Acquired Auto- inflammatory Disorders | Innovation theatre |
14:30 | Exhibition closes | |
14:15 - 15:45 | Afternoon sessions | |
Best Practice Awards 2018 | 1B | |
Clinical conundrums | 3B | |
Management of systemic complications of scleroderma | 4 | |
Physical activity in rheumatology: development through to implementation | 3A | |
Systemic lupus erythematosus throughout the ages | 1C | |
Understanding and managing pain in rheumatoid arthritis | 12 | |
15:45 - 16:00 | Refreshment break (for special interest group sessions) | |
16:00 | Registration closes | |
16:00 - 17:30 | Afternoon special interest group sessions | |
Adolescent and young adult - SIG | 4 | |
Crystal arthritis - SIG | 3A | |
Scleroderma - SIG | 3B | |
Vasculitis - SIG | 12 | |
More events
Sun, 5 May 2024 - Wed, 8 May 2024
Georgia World Congress Center
285 Andrew Young International Blvd, NW Atlanta
Georgia, 30313
United States
Georgia, 30313
United States
Mon, 6 May 2024 - Thu, 9 May 2024
Mon, 6 May 2024 - Thu, 9 May 2024
Tue, 7 May 2024 - Wed, 8 May 2024
Wed, 8 May 2024 - Thu, 9 May 2024
Thu, 9 May 2024 - Fri, 10 May 2024
Thu, 9 May 2024 - Sun, 12 May 2024
Thu, 9 May 2024 - Sat, 11 May 2024
Sat, 11 May 2024 - Tue, 14 May 2024
Sat, 11 May 2024 - Thu, 16 May 2024
